Silibinin declines blue light-induced apoptosis and inflammation through MEK/ERK/CREB of retinal ganglion cells

References

• Conlon R, Saheb H, Ahmed II. Glaucoma treatment trends: a review. Can J Ophthalmol. 2017;52(1):114–124.
   PubMed Web of Science ®Google Scholar
• Rukmini AV, Milea D, Gooley JJ. Chromatic pupillometry methods for assessing photoreceptor health in retinal and optic nerve diseases. Front Neurol. 2019;10:76.
   PubMed Web of Science ®Google Scholar
• Yadav KS, Rajpurohit R, Sharma S. Glaucoma: current treatment and impact of advanced drug delivery systems. Life Sci. 2019;221:362–376.
   PubMed Web of Science ®Google Scholar
• Lusthaus J, Goldberg I. Current management of glaucoma. Med J Aust. 2019;210(4):180–187.
   PubMed Web of Science ®Google Scholar
• Wang C, Ren YL, Zhai J, et al. Down-regulated LAMA4 inhibits oxidative stress-induced apoptosis of retinal ganglion cells through the MAPK signaling pathway in rats with glaucoma. Cell Cycle. 2019;18(9):932.
   PubMed Web of Science ®Google Scholar
• Peng H, Sun YB, Hao JL, et al. Neuroprotective effects of overexpressed microRNA-200a on activation of glaucoma-related retinal glial cells and apoptosis of ganglion cells via downregulating FGF7-mediated MAPK signaling pathway. Cell Signal. 2019;54:179–190.
   PubMed Web of Science ®Google Scholar
• Aires ID, Boia R, Rodrigues-Neves AC, et al. Blockade of microglial adenosine A2A receptor suppresses elevated pressure-induced inflammation, oxidative stress, and cell death in retinal cells. Glia. 2019;67(5):896–914.
   PubMed Web of Science ®Google Scholar
• Zhu XX, Ding YH, Wu Y, et al. Silibinin: a potential old drug for cancer therapy. Expert Rev Clin Pharmacol. 2016;1–8:1323–1330.
   Web of Science ®Google Scholar
• Federico A, Dallio M, Loguercio C. Silymarin/silybin and chronic liver disease: a marriage of many years. Molecules. 2017;22(2):191.
   PubMed Web of Science ®Google Scholar
• Lin CH, Li CH, Liao PL, et al. Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway. Br J Pharmacol. 2013;168(4):920–931.
   PubMed Web of Science ®Google Scholar
• Donadoni ML, Gavezzotti R, Borella F, et al. Experimental diabetic neuropathy. Inhibition of protein mono-ADP-ribosylation prevents reduction of substance P axonal transport. J Pharmacol Exp Ther. 1995;274(1):570–576.
   PubMed Web of Science ®Google Scholar
• Becker S, Eastlake K, Jayaram H, et al. Allogeneic transplantation of Muller-derived retinal Ganglion cells improves retinal function in a feline model of Ganglion cell depletion. Stem Cells Transl Med. 2016;5(2):192–205.
   PubMed Web of Science ®Google Scholar
• Mallick DJ, Soderquist RS, Bates D, et al. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477. Cell Death Dis. 2019;10(3):185.
   PubMed Web of Science ®Google Scholar
• Li JY, Zhang K, Xu D, et al. Mitochondrial fission is required for blue light-induced apoptosis and mitophagy in retinal neuronal R28 cells. Front Mol Neurosci. 2018;11:432.
   PubMed Web of Science ®Google Scholar
• Osborne A, Sanderson J, Martin KR. Neuroprotective effects of human mesenchymal stem cells and platelet-derived growth factor on human retinal Ganglion cells. Stem Cells. 2018;36(1):65–78.
   PubMed Web of Science ®Google Scholar
• Williams PA, Marsh-Armstrong N, Howell GR. Neuroinflammation in glaucoma: a new opportunity. Exp Eye Res. 2017;157:20–27.
   PubMed Web of Science ®Google Scholar
• Harun-Or-Rashid M, Inman DM. Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma. J Neuroinflammation. 2018;15(1):313.
   PubMed Web of Science ®Google Scholar
• Adornetto A, Russo R, Parisi V. Neuroinflammation as a target for glaucoma therapy. Neural Regen Res. 2019;14(3):391–394.
   PubMed Web of Science ®Google Scholar
• Bosch-Barrera J, Queralt B, Menendez JA. Targeting STAT3 with silibinin to improve cancer therapeutics. Cancer Treat Rev. 2017;58:61–69.
   PubMed Web of Science ®Google Scholar
• Salomone F, Barbagallo I, Godos J, et al. Silibinin restores NAD(+) levels and induces the SIRT1/AMPK pathway in non-alcoholic fatty liver. Nutrients. 2017;9(10):1086.
   PubMed Web of Science ®Google Scholar
• Byun HJ, Darvin P, Kang DY, et al. Silibinin downregulates MMP2 expression via Jak2/STAT3 pathway and inhibits the migration and invasive potential in MDA-MB-231 cells. Oncol Rep. 2017;37(6):3270–3278.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye J, Cao Y, et al. Silibinin ameliorates diabetic nephropathy via improving diabetic condition in the mice. Eur J Pharmacol. 2019;845:24–31.
   PubMed Web of Science ®Google Scholar
• Chi W, Chen H, Li F, et al. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation. 2015;12:137.
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang Y, Liang Z, et al. Silybin-mediated inhibition of Notch signaling exerts antitumor activity in human hepatocellular carcinoma cells. PLOS One. 2013;8(12):e83699.
   PubMed Web of Science ®Google Scholar
• Garcia S, Lopez E, Lopez-Colome AM. Glutamate accelerates RPE cell proliferation through ERK1/2 activation via distinct receptor-specific mechanisms. J Cell Biochem. 2008;104:377–390.
   PubMed Web of Science ®Google Scholar
• Gomez M, Manzano A, Figueras A, et al. Sertoli-secreted FGF-2 induces PFKFB4 isozyme expression in mouse spermatogenic cells by activation of the MEK/ERK/CREB pathway. Am J Physiol Endocrinol Metab. 2012;303:E695–E707.
   PubMed Web of Science ®Google Scholar